Mayo Clinic announces 2019 Discovery Science Award recipients

The Mayo Clinic Center for Biomedical Discovery announced 2019 Discovery Science Award recipients. These awards fund teams working on innovative, cutting-edge discovery science with a focus on understanding biological processes that contribute to human disease.

“Understanding How UCH-L1 Regulates mRNA Translation in the B-Cell Development and B-Cell Lymphomagenesis”

Department of Pediatric and Adolescent Medicine and subspecialties
Paul Galardy, M.D. (PDHO ’06)

“Leukemic Extracellular Vesicles Modulate Chimeric Antigen Receptor T-Cell Immunotherapy”

Principal investigator: Saad Kenderian, M.B., Ch.B. (HEMO ’13), Division of Hematology, Department of Medicine; Department of Molecular Medicine; Department of Immunology, Mayo Clinic Rochester

Co-investigators: Neil Kay, M.D. (HEMO ’99), Division of Hematology, Department of Medicine, Mayo Clinic Rochester

Fabrice Lucien-Matteoni, Ph.D. (RS ’17), Department of Urology, Mayo Clinic Rochester

“Elucidating the Mechanisms Through Which HP1a Contributes to Colon Cancer Metastasis”

Principal investigator: Hu Li, Ph.D. (MPET ’13), Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester

Co-investigators: Martin Fernandez-Zapico, M.D. (GI ’02), Division of Medical Oncology, Department of Oncology; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Rochester

Steven Offer, Ph.D. (MPET ’13), Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester

“Novel Mechanisms of pH-Mediated Metabolic Reprogramming in Type 2 Diabetes Mellitus”

Principal investigator: Aleksey Matveyenko, Ph.D. (PHYS ’14), Department of Physiology and Biomedical Engineering; Division of Endocrinology, Diabetes, Metabolism, & Nutrition, Department of Medicine, Mayo Clinic Rochester

Co-investigators: Michael Romero, Ph.D. (PHYS ’06), Department of Physiology and Biomedical Engineering; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic Rochester

Taro Hitosugi, Ph.D. (ONCL ’13), Department of Molecular Pharmacology and Experimental Therapeutics; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic Rochester

“Understanding Hydrogen Sulfide Signaling in Neonatal Airway Disease”

“Stearoyl-COA Deasaturase-Mediated Fatty Acid Metabolism Controls B Cell Differentiation”

Principal investigator: Hu Zeng, Ph.D. (RS ’17), Division of Rheumatology, Department of Medicine; Department of Immunology, Mayo Clinic Rochester

Co-investigators: John Copland II, Ph.D. (CBS ’03), Department of Cancer Biology, Mayo Clinic Florida

Ian Lanza, Ph.D. (ENDO ’09, CTSA ’13), Division of Endocrinology, Diabetes, Metabolism, & Nutrition, Department of Medicine; Department of Physiology and Biomedical Engineering, Mayo Clinic Rochester

Uma Thanarajasingam, M.D., Ph.D. (IMM ’08, MDPH ’08, I ’11, CMR ’12), Division of Rheumatology, Department of Medicine, Mayo Clinic Rochester

Mariam Alexander, M.D. (APATH ’12), Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester

 

 

Recommended reading

Posts about similar topics: